Replies to post #444 on Cynapsus Therapeutics Inc. (CYNA)

[noretreat]

I asked Anthony the same question after the presentation and he said it was dose related....so he agrees with you.

For the second year in a row it was an impressive presentation and a good plan. The key now is just to get through P3 and find the right buyer.

It should slowly rise, independent of market trends, to around 3 bucks in my view.

[CHM_760]

Thanks for your reply... in reading about injectible apomorphine, it appears to have non-responders as well.